SNCA and Parkinson disease: Although 6-OHDA does not induce intracellular α-synuclein aggregation or Lewy body formation—key pathological hallmarks of human PD—it remains central to preclinical research due to its reproducibility, rapid onset, and suitability for evaluating restorative strategies such as cell replacement, neurotrophic factors, and gene therapies [146].